Showing results (11-20 of 248) with videos related to
Sort By:
Pageof 25
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1994
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patientsL Frattola, M Garreau, R Piolti, et al.Archives of Neurology|April 1, 1979
Hemiparkinsonism. A human model for studying dopaminergic supersensitivityM Trabucchi, M G Albizzati, L Frattola, et al.Clinical Neuropharmacology|December 1, 1992
Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trialL Frattola, R Piolti, S Bassi, et al.Acta Neurologica Scandinavica|September 1, 1976
F-wave velocity in motor neurone diseaseM G Albizzati, S Bassi, D Passerini, et al.Rivista Di Patologia Nervosa E Mentale|September 1, 1976
[Clinical and anatomical features of a case of Schilder's disease (author's transl)]M G Albizzati, S Bassi, C Mariani, et al.Current Medical Research and Opinion|January 1, 1980
Effects of vincamine on EEG sleep patterns in man: a pilot studyM G Albizzati, S Bassi, G Binda, et al.Journal of Neurosurgical Sciences|July 1, 1974
Adenyl cyclase and phosphodiesterase in human cerebral tumorsN Canal, L Frattola, R Villani, et al.Acta Neurologica Scandinavica|June 1, 1986
Different patterns of CSF neurotransmitter metabolism in patients with left or right hemispheric strokeC Ferrarese, S Bassi, L Frattola, et al.European Neurology|January 1, 1991
Effects of a MAO-B inhibitor in the treatment of Alzheimer diseaseA Mangoni, M P Grassi, L Frattola, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's diseaseC Ferrarese, L Tremolizzo, M Rigoldi, et al.Pageof 25